Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

HEMORR2HAGES

HEMORR2HAGES: Estimates bleeding risk in patients with atrial fibrillation. A score ≥4 indicates high risk (~10%+ annual bleeding rate).

Hepatic or Renal Disease

Cirrhosis, elevated bilirubin, or CrCl < 30 mL/min

Ethanol (Alcohol) Abuse

Current or recent history of excessive consumption

Malignancy

Active malignancy or recent treatment

Age > 75 Years
Reduced Platelet Count/Function

Platelets < 100k or on antiplatelet therapy

Rebleeding Risk+2 pts

Prior major bleed

Uncontrolled Hypertension

SBP > 160 mmHg currently

Anemia

Hct < 30% or Hb < 10 g/dL

Genetic Factors

CYP2C9*2 and/or *3, or other high-risk SNPs

Elevated Fall Risk

History of falls, gait instability, or frailty

Stroke History

Prior stroke, TIA, or thromboembolism

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

How it Works

Clinical Pearls

Next Steps

The Evidence

Origins & History

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

Cancer MedicineJul 23, 2026
High SIGLEC10‐Expressing Tumor‐Associated Macrophages Participate in Remodeling the Tumor Immune Microenvironment and Predict Poor Prognosis in Colorectal Cancer

Clinical Context

We think this might be relevant to the clinical guidance for HEMORR 2 HAGES.

WHO NewsJul 2, 2026
WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing

Clinical Context

We think this has broad domain relevance to HEMORR 2 HAGES.

BJOGJun 25, 2026
Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

Clinical Context

We think this has broad domain relevance to HEMORR 2 HAGES.